Plunkett Research Online: XORTX Therapeutics

XORTX THERAPEUTICS (XRTX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such .....


XORTX THERAPEUTICS

Ticker: XRTX
Exchange: TSXV
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 403 607-2621
Fax: 403 260-3501
Address: 745 Thurlow St., Ste. 2400
Vancouver, BC V6E 0C5 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Allen DavidoffCEO/Director/President
James FairbairnCFO
See More
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such .....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture